Adaptimmune stock plunges after announcing Nasdaq delisting plans
Alphabet (NASDAQ:GOOGL), the $3.07 trillion tech giant trading near its 52-week high of $256.96, saw its VP, Chief Accounting Officer Amie Thuener O’Toole, sell 2,778 shares of Class C Capital Stock on October 15, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The sales were executed at prices ranging from $247.49 to $252.31, resulting in a total transaction value of $694650.
Following the transactions, O’Toole directly owns 14516 shares of Class C Capital Stock. She also directly owns 8940 shares of Class A Common Stock, 14945 Class C Google Stock Units, and 16283 Class C Google Stock Units.
These transactions were executed under a Rule 10b5-1 trading plan adopted on May 23, 2025.
In other recent news, Google has announced a significant investment of $15 billion to establish its first Artificial Intelligence hub in India. This investment, planned over the next five years, marks Google’s largest commitment in the country and will include gigawatt-scale data center operations, new energy sources, and an expanded fiber-optic network. Additionally, Google is set to invest $9 billion in South Carolina to enhance its AI infrastructure, with plans extending through 2027 to expand the Berkeley County data center and develop new sites in Dorchester County. Meanwhile, Alphabet’s Verily has launched a new consumer health app called Verily Me, providing personalized health recommendations from licensed clinicians based on comprehensive medical records. On the technology front, Google has unveiled Veo 3.1, an updated version of its AI filmmaking tool, Flow, incorporating audio capabilities in response to user feedback. Furthermore, Google has made strides in cancer research with its Gemma model, which has led to the discovery of a potential new pathway for cancer therapy development. These developments highlight Google’s ongoing efforts in expanding its technological and healthcare capabilities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.